Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nrf2 Activation Sensitizes K-Ras Mutant Pancreatic Cancer Cells to Glutaminase Inhibition
Shin Hamada, Ryotaro Matsumoto, Yu Tanaka, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1870-1870
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Glutamine addiction in tumor cell: oncogene regulation and clinical treatment
Xian Li, Xueqiang Peng, Yan Li, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 23
Role of hypoxia in the tumor microenvironment and targeted therapy
Gaoqi Chen, Kaiwen Wu, Hao Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 70
Metabolomics-assisted discovery of a new anticancer GLS-1 inhibitor chemotype from a nortopsentin-inspired library: From phenotype screening to target identification
Daniela Carbone, Vincenzo Vestuto, Maria Rosalia Ferraro, et al.
European Journal of Medicinal Chemistry (2022) Vol. 234, pp. 114233-114233
Closed Access | Times Cited: 42
The Multi-Faceted Consequences of NRF2 Activation throughout Carcinogenesis
Christopher J. Occhiuto, Jessica A. Moerland, Ana S. Leal, et al.
Molecules and Cells (2023) Vol. 46, Iss. 3, pp. 176-186
Open Access | Times Cited: 22
KRAS Hijacks the miRNA Regulatory Pathway in Cancer
Angelina S. Bortoletto, Ronald J. Parchem
Cancer Research (2023) Vol. 83, Iss. 10, pp. 1563-1572
Open Access | Times Cited: 20
Liquid‒liquid phase separation: roles and implications in future cancer treatment
Zheran Liu, Zijian Qin, Yingtong Liu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 13, pp. 4139-4156
Open Access | Times Cited: 17
Stress Granules Involved in Formation, Progression and Metastasis of Cancer: A Scoping Review
Mohammad Reza Asadi, Dara Rahmanpour, Marziyeh Sadat Moslehian, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 34
KEAP1/NFE2L2 Pathway Signature Outperforms KEAP1/NFE2L2 Mutation Status and Reveals Alternative Pathway-Activating Mutations in NSCLC
Christoph Arolt, Margaret Dugan, Robert Wild, et al.
Journal of Thoracic Oncology (2023) Vol. 18, Iss. 11, pp. 1550-1567
Open Access | Times Cited: 15
Oxidative Stress and Cancer Heterogeneity Orchestrate NRF2 Roles Relevant for Therapy Response
Koraljka Gall‐Trošelj, Marko Tomljanović, Morana Jaganjac, et al.
Molecules (2022) Vol. 27, Iss. 5, pp. 1468-1468
Open Access | Times Cited: 21
Molecular Research in Pancreatic Cancer: Small Molecule Inhibitors, Their Mechanistic Pathways and Beyond
Shaila A. Shetu, Nneoma James, Gildardo Rivera, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 3, pp. 1914-1949
Open Access | Times Cited: 11
HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic Cancer
Shin Hamada, Ryotaro Matsumoto, Atsushi Masamune
Cancers (2022) Vol. 14, Iss. 2, pp. 411-411
Open Access | Times Cited: 18
SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway
Rabab S. Hamad, Hayder M. Al‐kuraishy, Αθανάσιος Αλεξίου, et al.
Cell Stress and Chaperones (2023) Vol. 28, Iss. 6, pp. 657-673
Open Access | Times Cited: 11
Targeting the crosstalk between glutamine metabolism and tumor immune microenvironment for lung cancer immunotherapy
Jingyang Li, Xiang Li, Shaohui Wang, et al.
Deleted Journal (2025)
Open Access
Targeted mitochondrial therapy for pancreatic cancer
Xinya Zhao, Guoyu Wu, Xufeng Tao, et al.
Translational Oncology (2025) Vol. 54, pp. 102340-102340
Closed Access
Metabolic reprogramming of drug resistance in pancreatic cancer: mechanisms and effects
Jinyi Zhang, Xueqing Kong, Boyan Zhou, et al.
Molecular Aspects of Medicine (2025) Vol. 103, pp. 101368-101368
Closed Access
Role of Nrf2 in Pancreatic Cancer
Marta Cykowiak, Violetta Krajka‐Kuźniak
Antioxidants (2021) Vol. 11, Iss. 1, pp. 98-98
Open Access | Times Cited: 23
The possible role of nuclear factor erythroid‐2‐related factor 2 activators in the management of Covid‐19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Omayma A. Eldahshan, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 9
GLS and GLS2 Glutaminase Isoenzymes in the Antioxidant System of Cancer Cells
Juan de los Santos-Jiménez, José A. Campos‐Sandoval, Francisco J. Alonso, et al.
(2024)
Open Access | Times Cited: 2
Rethinking our approach to cancer metabolism to deliver patient benefit
Saverio Tardito, Craig MacKay
British Journal of Cancer (2023) Vol. 129, Iss. 3, pp. 406-415
Closed Access | Times Cited: 4
GLS and GLS2 Glutaminase Isoenzymes in the Antioxidant System of Cancer Cells
Juan de los Santos-Jiménez, José A. Campos‐Sandoval, Francisco J. Alonso, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 745-745
Open Access | Times Cited: 1
Targeting aberrant amino acid metabolism for pancreatic cancer therapy: Opportunities for nanoparticles
Xinlong Zang, Ke Lei, Jia Wang, et al.
Chemical Engineering Journal (2024) Vol. 498, pp. 155071-155071
Closed Access | Times Cited: 1
Development of a Rapid In Vitro Screening Assay Using Metabolic Inhibitors to Detect Highly Selective Anticancer Agents
Felagot A. Abebe, Megan D. Hopkins, Suraj N. Vodnala, et al.
ACS Omega (2021) Vol. 6, Iss. 28, pp. 18333-18343
Open Access | Times Cited: 9
Nrf2 expression in pancreatic stellate cells promotes progression of cancer
Yu Tanaka, Shin Hamada, Ryotaro Matsumoto, et al.
AJP Gastrointestinal and Liver Physiology (2021) Vol. 321, Iss. 4, pp. G378-G388
Closed Access | Times Cited: 9
Gender specific eRNA TBX5-AS1 as the immunological biomarker for male patients with lung squamous cell carcinoma in pan-cancer screening
Tao Yan, Kai Wang, Qidi Zhao, et al.
PeerJ (2021) Vol. 9, pp. e12536-e12536
Open Access | Times Cited: 7
Small molecule inhibitors for cancer metabolism: promising prospects to be explored
Dan Liu, Hongping Wang, Xingxing Li, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 10, pp. 8051-8076
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top